Bsc: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
{{PAGENAME}} - the nci board of scientific counselors comprised of leading scientists and members of the lay community, advises the directors of the intramural division of the nci and the director and deputy director, nci, on the matters concerning scientific program policy and the progress and future direction of research programs of each division, including the evaluation of performance and productivity of each division and staff scientists through periodic site visits to intramural laboratories, and evaluation and advice on the course of each division's programs.
{{Infobox medical condition
{{med-stub}}
| name = Biliary Cirrhosis
{{dictionary-stub2}}
| image =
{{short-articles-ni}}
| caption =
| field = [[Hepatology]]
| symptoms = Fatigue, pruritus, jaundice
| complications = [[Liver failure]], [[portal hypertension]], [[osteoporosis]]
| onset =
| duration =
| causes = Autoimmune destruction of bile ducts
| risks = Female gender, genetic predisposition
| diagnosis = [[Liver biopsy]], [[antimitochondrial antibody]] test
| treatment = Ursodeoxycholic acid, liver transplant
| prognosis = Variable, depends on stage at diagnosis
| frequency =
}}
 
==Overview==
'''Biliary Cirrhosis''' is a chronic liver disease characterized by progressive destruction of the small and medium-sized bile ducts within the liver. This leads to cholestasis, fibrosis, and eventually cirrhosis. The condition is primarily autoimmune in nature and is more prevalent in women.
 
==Pathophysiology==
The pathogenesis of biliary cirrhosis involves an autoimmune attack on the bile ducts. The immune system mistakenly targets the epithelial cells lining the bile ducts, leading to inflammation and destruction. Over time, this results in cholestasis, where bile cannot flow from the liver to the duodenum, causing liver damage and fibrosis.
 
==Clinical Presentation==
Patients with biliary cirrhosis often present with non-specific symptoms such as fatigue and pruritus. As the disease progresses, jaundice, hepatomegaly, and signs of portal hypertension may develop. Advanced disease can lead to complications such as liver failure and osteoporosis.
 
==Diagnosis==
Diagnosis of biliary cirrhosis is based on clinical, biochemical, and histological findings. Key diagnostic tests include:
* [[Liver function tests]] showing cholestatic pattern
* Presence of [[antimitochondrial antibodies]] (AMA) in the blood
* [[Liver biopsy]] demonstrating bile duct destruction and fibrosis
 
==Management==
The primary treatment for biliary cirrhosis is ursodeoxycholic acid, which can slow disease progression. In cases of advanced cirrhosis, liver transplantation may be necessary. Management also includes addressing symptoms such as pruritus and monitoring for complications like osteoporosis.
 
==Prognosis==
The prognosis of biliary cirrhosis varies depending on the stage at diagnosis and response to treatment. Early diagnosis and treatment can improve outcomes, but advanced disease may lead to liver failure and require transplantation.
 
==Epidemiology==
Biliary cirrhosis is more common in women, with a female-to-male ratio of approximately 9:1. It typically presents in middle-aged individuals, although it can occur at any age.
 
==See Also==
* [[Cirrhosis]]
* [[Autoimmune hepatitis]]
* [[Primary sclerosing cholangitis]]
 
==External Links==
* [https://www.liverfoundation.org/ American Liver Foundation]
* [https://www.hepatitis.org/ Hepatitis Foundation International]
 
{{Medical resources}}
 
[[Category:Hepatology]]
[[Category:Liver diseases]]
[[Category:Autoimmune diseases]]

Latest revision as of 17:18, 1 January 2025

Biliary Cirrhosis
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Fatigue, pruritus, jaundice
Complications Liver failure, portal hypertension, osteoporosis
Onset
Duration
Types N/A
Causes Autoimmune destruction of bile ducts
Risks Female gender, genetic predisposition
Diagnosis Liver biopsy, antimitochondrial antibody test
Differential diagnosis N/A
Prevention N/A
Treatment Ursodeoxycholic acid, liver transplant
Medication N/A
Prognosis Variable, depends on stage at diagnosis
Frequency
Deaths N/A


Overview[edit]

Biliary Cirrhosis is a chronic liver disease characterized by progressive destruction of the small and medium-sized bile ducts within the liver. This leads to cholestasis, fibrosis, and eventually cirrhosis. The condition is primarily autoimmune in nature and is more prevalent in women.

Pathophysiology[edit]

The pathogenesis of biliary cirrhosis involves an autoimmune attack on the bile ducts. The immune system mistakenly targets the epithelial cells lining the bile ducts, leading to inflammation and destruction. Over time, this results in cholestasis, where bile cannot flow from the liver to the duodenum, causing liver damage and fibrosis.

Clinical Presentation[edit]

Patients with biliary cirrhosis often present with non-specific symptoms such as fatigue and pruritus. As the disease progresses, jaundice, hepatomegaly, and signs of portal hypertension may develop. Advanced disease can lead to complications such as liver failure and osteoporosis.

Diagnosis[edit]

Diagnosis of biliary cirrhosis is based on clinical, biochemical, and histological findings. Key diagnostic tests include:

Management[edit]

The primary treatment for biliary cirrhosis is ursodeoxycholic acid, which can slow disease progression. In cases of advanced cirrhosis, liver transplantation may be necessary. Management also includes addressing symptoms such as pruritus and monitoring for complications like osteoporosis.

Prognosis[edit]

The prognosis of biliary cirrhosis varies depending on the stage at diagnosis and response to treatment. Early diagnosis and treatment can improve outcomes, but advanced disease may lead to liver failure and require transplantation.

Epidemiology[edit]

Biliary cirrhosis is more common in women, with a female-to-male ratio of approximately 9:1. It typically presents in middle-aged individuals, although it can occur at any age.

See Also[edit]

External Links[edit]